Newrology
A fresh approach to helping patients thrive
A pipeline for patient-kind
Harmony Biosciences’ patient-focused drug development model uses patient insights to inform clinical research programs.
The Struggle to Stay Awake: Recognizing Pediatric Narcolepsy
In this television broadcast about pediatric narcolepsy from The Lifetime Network, sponsored by Harmony Biosciences, learn about this often underdiagnosed and misdiagnosed disorder and meet a mother who trusted her instincts to help her son.
Nov 4, 2025
Harmony Biosciences Reports Strong Q3 2025 Financial Results; Recently Raised 2025 Revenue Guidance to $845-$865M
Oct 23, 2025
Harmony Biosciences Preannounces Strong Q3 2025 WAKIX Performance; Raises 2025 Revenue Guidance
Sep 24, 2025
Harmony Biosciences Provides Update From Its Phase 3 RECONNECT Study of ZYN002 in Fragile X Syndrome
available now
Discover our Products
From discovery to delivery, Harmony Biosciences is committed to getting medicines to the people who need them most.
The Harmony Team
Meet our leaders who share an uncommon commitment for addressing patients’ unmet medical needs.
Senior Leadership